Skip to content
MMJ Gazette
  Wednesday 14 January 2026
  • About
  • Contact Us
  • Privacy Policy
  • Terms and Conditions
  • Authors
  • Home
  • News
  • CBD
  • Cannabis
  • Drugs
  • Marijuana
  • Tobacco
  • Law
Trending
January 13, 2026Texas Medical Cannabis Set to Explode in 2026 January 10, 2026Cannabis Firms Face HR Compliance Crunch in 2026 January 9, 2026Oregon Cannabis Sales Drop in 2025 Despite Record Harvests January 8, 2026Kentucky’s Medical Weed Market Faces Major Supply Hurdles January 7, 2026Vireo Growth Buys Eaze in $47M Cannabis Shakeup January 5, 2026Chanda Macias Drives Global Medical Cannabis Access January 3, 2026Trump’s Marijuana Shift: Answers to Your Burning Questions on Tax Relief January 2, 2026Marijuana Rescheduling Sparks Tax Relief Hopes – But When? January 1, 2026Three Trends Reshaping U.S. Cannabis in 2026 December 30, 2025Trump’s Cannabis Shift Sparks Hope for Parkinson’s Relief
MMJ Gazette
MMJ Gazette
  • About
  • Contact Us
  • Privacy Policy
  • Terms and Conditions
  • Authors
MMJ Gazette
  Cannabis  California Bill Seeks to Repeal Hemp-Derived THC Ban, But With Key Restrictions
CannabisNews

California Bill Seeks to Repeal Hemp-Derived THC Ban, But With Key Restrictions

Lars BeckersLars Beckers—January 9, 20250
FacebookTwitterPinterestLinkedInTumblrRedditVKWhatsAppEmail

California lawmakers are considering a bill that could bring hemp-derived THC products back to shelves—but with stricter regulations. Assembly Bill 8, introduced by Democratic Assembly Majority Leader Cecilia Aguiar-Curry, aims to reverse a controversial ban imposed under emergency regulations last year, while also establishing guardrails to prevent unregulated and potentially harmful products from flooding the market.

What the Bill Proposes

Under AB8, hemp-derived THC products would regain legality in California, provided they meet a series of specific requirements. The bill outlines clear conditions to ensure compliance with existing state laws and industrial hemp regulations. Here’s what the proposed framework includes:

  • Delta-9 THC Limit: Products must not exceed 0.3% delta-9 THC on a dry weight basis, aligning with federal guidelines for industrial hemp.
  • Exclusion of Synthetic Cannabinoids: Cannabinoids produced through chemical synthesis would remain illegal.
  • Ban on THC Isolate as an Ingredient: Products containing THC isolate would still be prohibited.

These measures reflect an attempt to balance public safety concerns with the demands of hemp advocates, who argue that the previous ban unfairly decimated a thriving market.

Addressing the THCA Loophole

California’s approach to regulating THC products also acknowledges a significant point of contention in the hemp industry: the THCA loophole. This loophole, exploited in some states, allows producers to market intoxicating flower as federally legal hemp by emphasizing its tetrahydrocannabinolic acid (THCA) content rather than THC.

Under AB8, California law calculates “total THC” as the sum of THC and THCA, closing this loophole. This calculation aims to prevent intoxicating products from masquerading as legal hemp while maintaining consistency with the state’s stringent cannabis regulations.

Industry Reactions: Relief and Resistance

Hemp advocates see the bill as a step forward after Governor Gavin Newsom’s emergency regulations effectively wiped out 90%-95% of the hemp-derived products on the market. However, regulated marijuana businesses, already burdened by heavy taxes and strict oversight, remain wary of the bill.

For these businesses, the rise of hemp-derived THC gummies and other intoxicating products represents a significant challenge. Such products often bypass the rigorous regulations imposed on the legal cannabis industry, creating an uneven playing field. Critics argue that AB8, while addressing some concerns, doesn’t go far enough to curb the proliferation of unregulated intoxicants.

A representative of a California cannabis retailer, who wished to remain anonymous, expressed concerns: “This bill might bring clarity, but it still allows for competition from hemp products that don’t face the same scrutiny we do. It’s frustrating.”

A Compromise or a Half-Measure?

The debate over AB8 underscores the tension between fostering innovation in the hemp industry and protecting the integrity of California’s regulated cannabis market. By allowing certain hemp-derived THC products while excluding synthetic cannabinoids and THC isolates, the bill seeks to strike a balance.

Still, questions remain. Would these new regulations truly reinvigorate the hemp industry, or would they merely create new hurdles? And what about the consumers—will they feel confident in the safety and legality of these products?

FacebookTwitterPinterestLinkedInTumblrRedditVKWhatsAppEmail

Lars Beckers

Lars Beckers is a distinguished senior content writer at MMJ Gazette, bringing a wealth of experience and expertise to the realm of medical marijuana and cannabis-related content. With a deep understanding of the industry and a passion for sharing knowledge, Lars's articles offer readers comprehensive insights and engaging narratives in the dynamic world of cannabis. Known for his meticulous research, clarity of expression, and commitment to delivering high-quality content, Lars brings a seasoned perspective to his work, educating and informing audiences on the latest trends and developments in the field.

Florida Judge Blocks GTI’s Plan to Open Medical Cannabis Stores Near Circle K Locations
Safe Harbor Financial Cuts $1.2M Liability with New Agreement
Related posts
  • Related posts
  • More from author
Cannabis

Texas Medical Cannabis Set to Explode in 2026

January 13, 20260
Cannabis

Cannabis Firms Face HR Compliance Crunch in 2026

January 10, 20260
Cannabis

Oregon Cannabis Sales Drop in 2025 Despite Record Harvests

January 9, 20260
Load more
Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

SEARCH
PROMOTIONS
RECENT POSTS
  • Texas Medical Cannabis Set to Explode in 2026
  • Cannabis Firms Face HR Compliance Crunch in 2026
  • Oregon Cannabis Sales Drop in 2025 Despite Record Harvests
  • Kentucky’s Medical Weed Market Faces Major Supply Hurdles
  • Vireo Growth Buys Eaze in $47M Cannabis Shakeup
  • Chanda Macias Drives Global Medical Cannabis Access
  • Trump’s Marijuana Shift: Answers to Your Burning Questions on Tax Relief
  • Marijuana Rescheduling Sparks Tax Relief Hopes – But When?
  • Three Trends Reshaping U.S. Cannabis in 2026
  • Trump’s Cannabis Shift Sparks Hope for Parkinson’s Relief
    © MMJ Gazette. 2024
    • About
    • Contact Us
    • Privacy Policy
    • Terms and Conditions
    • Authors